companies making glp-1 drugs from the Gray Market Compound versions of GLP-1 drugs
Description
[1] Adverse effects [edit] The safety profile of retatrutide is still under investigation
No increase in the risk of amputations or ketoacidosis was reported
doi: 10.1002/dmrr.70029 25 MilaniIGuariscoGChinucciMGaitaCLeonettiFCapocciaD
Thanks for reading Ground Truths
doi: 10.1016/j.rbmo.2019.04.017 [DOI] [PubMed] [Google Scholar] 203
to use this drug you will need to prepare a new needle and set the appropriate dosage on the pen for each use
